Taf + Emtricitabine + Rilpivirine Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: (TAF) – 25 mg + Emtricitabine – 200 mg + Rilpivirine – 25 mg

Reference Brands: Odefsey(US & EU)

Category: Anti Viral

TAF + Emtricitabine + Rilpivirine is available in Tablet and strengths such as (TAF) – 25 mg + Emtricitabine – 200 mg + Rilpivirine – 25 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, TAF + Emtricitabine + Rilpivirine is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

TAF + Emtricitabine + Rilpivirine can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Odefsey is a once-daily, fixed-dose combination tablet containing Tenofovir Alafenamide (TAF) 25 mg, Emtricitabine 200 mg, and Rilpivirine 25 mg, used for the treatment of HIV-1 infection in virologically suppressed patients or treatment-naïve individuals without resistance to its components. Approved by the FDA and EMA, Odefsey is a TAF-based alternative to older TDF regimens like Complera/Eviplera, offering improved renal and bone safety. It is indicated for adults and adolescents (≥12 years and ≥35 kg) and must be taken with a meal. Odefsey simplifies therapy by combining three potent agents into a single-tablet regimen.